Acute hepatitis due to olmesartan: an uncommon entity.

Cristina Rubín de Célix, Rosario Serrano, Luisa García-Buey

Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 2021 Mar

filter terms:

all
compound
phenotype
show more »
show less «

We report the case of a hypertensive 54-year-old female who had been under treatment with olmesartan (40 mg daily) for a month. She was referred due to hypertransaminasemia and also reported asthenia and a 7 kg weight loss.

Citation

Cristina Rubín de Célix, Rosario Serrano, Luisa García-Buey. Acute hepatitis due to olmesartan: an uncommon entity. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2021 Mar;113(3):223-224